Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
36.6%
% of XPH's 41 holdings also in FTXH
30.0%
% of FTXH's 51 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 3.7% | 7.5% | 3.7% |
|
BRISTOL-MYERS SQUIBB CO | 3.7% | 7.6% | 3.7% |
|
ZOETIS INC | 3.7% | 3.7% | 3.7% |
|
PFIZER INC | 3.6% | 7.2% | 3.6% |
|
MERCK & CO. INC. | 3.5% | 7.3% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to FTXH
|
TARSUS PHARMACEUTICALS, INC. | 3.9% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% |
|
ROYALTY PHARMA PLC CLASS A | 3.5% |
|
EDGEWISE THERAPEUTICS, INC. | 3.2% |
|
CORCEPT THERAPEUTICS INC | 3.2% |
|
AXSOME THERAPEUTICS, INC. | 3.2% |
|
PACIRA PHARMACEUTICALS INC | 2.9% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 2.8% |
 |
PERRIGO CO | 2.8% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.8% |
XPH Underweight Relative to FTXH
|
ABBVIE INC | -7.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.9% |
|
AMGEN INC | -3.7% |
|
JOHNSON & JOHNSON | -3.7% |
|
MERCK & CO. INC. | -3.7% |
|
BIOGEN IDEC INC | -3.7% |
|
GILEAD SCIENCES INC | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
PFIZER INC | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.4% |